Auris Health, now part of Johnson & Johnson MedTech, is a pioneering company at the forefront of robotic-assisted surgical solutions. Founded with the vision of transforming minimally invasive procedures, Auris Health developed cutting-edge technologies to enhance precision, safety, and efficiency in complex medical interventions. The company’s flagship innovation, the MONARCH™ Platform, is a robotic-assisted bronchoscopy system designed to improve the diagnosis and treatment of lung conditions, enabling physicians to reach previously inaccessible areas with unparalleled accuracy.

Since its acquisition by Johnson & Johnson in 2019, Auris Health has leveraged the global reach, resources, and expertise of J&J’s Ethicon division to expand its impact in the surgical and healthcare ecosystem. The integration of Auris Health’s robotic technologies complements J&J’s commitment to innovation, advancing minimally invasive surgery and improving patient outcomes worldwide.

Auris Health stands out for its dedication to combining engineering excellence with clinical insight, creating solutions that empower surgeons, reduce procedural risks, and optimize patient care. By pushing the boundaries of medical robotics, the company continues to lead the evolution of surgical technology, shaping the future of healthcare. With a focus on precision, safety, and innovation, Auris Health represents a transformative force in modern medicine, delivering meaningful solutions to patients and clinicians alike.